Steven Hyman - Jul 25, 2022 Form 4/A - Amendment Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Stock symbol
CYCN
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/27/2022, 04:40 PM
Date Of Original Report
Jul 26, 2022
Previous filing
Jun 8, 2022
Next filing
Jun 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Stock Option (Right to Buy) Award $0 +57.8K $0.00 57.8K Jul 25, 2022 Common Stock 57.8K $0.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted pursuant to the director compensation plan. 17,753 options will vest in full on the first anniversary of the grant date and 40,000 options will vest monthly pro rata over 36 months starting on the grant date.

Remarks:

This amended Form 4 is being filed solely to correct the vesting periods of the options.